Abstract
Cigarette smoking is a risk factor for abdominal aortic aneurysms (AAAs), with studies suggesting a higher smoking-related AAA risk in women than men. We examined nicotine’s effects on angiotensin II (AngII)-induced AAAs in male and female low-density lipoprotein receptor-deficient (Ldlr-/-) mice. Moreover, we defined effects of gonadectomy (GDX) of both sexes on nicotine-induced regulation of AAAs. Male and female Ldlr-/- mice (8–12 weeks of age) were infused with AngII with or without nicotine. Mice underwent sham or GDX surgeries prior to infusions of AngII and nicotine. In males, one or both testes were removed. AAA incidence, size, severity, and serum indices of nicotine metabolism were quantified. Effects of testosterone or estrogen on abdominal aortic smooth muscle cells (SMCs) were assessed. Nicotine increased aortic rupture in males, with modest effects in females. GDX reduced AAA incidence in male mice but had modest effects in females. Serum ratios of trans-3-hydroxycotinine to cotinine, an index of nicotine metabolism, were higher in females and increased by GDX in both sexes. Co-infusion of nicotine with AngII increased matrix metalloproteinase 2 (MMP2) mRNA in abdominal aortas of males, but not females. Similarly, testosterone increased MMP2 mRNA in male, but not female abdominal aortic SMCs. Testosterone reduced markers of a contractile SMC phenotype in SMCs from males, with no effects of estrogen in females. In conclusion, nicotine augments AngII-induced AAAs to a greater extent in males, with sex differences related to influences of sex hormones on nicotine metabolism, aortic MMP2 expression, and markers of a contractile SMC phenotype.
Original language | English |
---|---|
Pages (from-to) | 411-429 |
Number of pages | 19 |
Journal | Clinical Science |
Volume | 139 |
Issue number | 8 |
DOIs | |
State | Published - Apr 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Author(s).
Funding
This research was supported by American Heart Association Strategically Focused Network on Vascular Diseases (AHA SFRN 19SFRB3390001, LAC), by the National Institutes of Health (R01HL168633, LAC), and through cores provided within NIH GM103527 (LAC). The authors thank Marsha Ensor for technical support.
Funders | Funder number |
---|---|
American the American Heart Association | SFRN 19SFRB3390001 |
American the American Heart Association | |
National Institutes of Health (NIH) | GM103527, R01HL168633 |
National Institutes of Health (NIH) |
ASJC Scopus subject areas
- General Medicine